The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

evoxx.com

Founded Year

2006

Stage

Acquired | Acquired

Total Raised

$7.22M

About evoxx technologies

evoxx technologies is a German industrial biotechnology company focused on the development and production of industrial enzymes. Product development is based on the proprietary technology platform covering the whole value chain from early enzyme and process development to industrial scale production and product deregulation.

evoxx technologies Headquarter Location

Alfred-Nobel-Str. 10

Monheim am Rhein, 40789,

Germany

+49 2173 4099-40

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing evoxx technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

evoxx technologies is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

evoxx technologies Patents

evoxx technologies has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/22/2016

7/13/2021

Molecular biology, Biotechnology, Proteins, Protein domains, Human proteins

Grant

Application Date

7/22/2016

Grant Date

7/13/2021

Title

Related Topics

Molecular biology, Biotechnology, Proteins, Protein domains, Human proteins

Status

Grant

Latest evoxx technologies News

evocatal GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

Nov 23, 2016

evocatal GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 10:26 EST 23 Nov 2016 | BioPortfolio Reports Home » Topics » Biotechnology - Biotech » Latest News » evocatal GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 Summary evocatal GmbH evocatal is a biotechnology company that develops and produces fine chemicals and enzymes for chemical and pharmaceutical companies. The company offers products including evozymes, evochemicals and evoglow. Its evozyme products include alcohol dehydrogenases, CC coupling kit, cofactor regeneration, hydroxynitrilases, lipases, TPP enzymes and transaminases. Evocatal provides fine chemicals such as diols, hydroxyesters, hydroxyketones, chiral building blocks and secondary alcohols. The company offers services, which include enzyme development, gene expression and process development. It is developing HTScreening tools to identify new or optimized biocatalysts. evocatal is headquartered in Monheim am Rhein, Germany. evocatal GmbH Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

  • When was evoxx technologies founded?

    evoxx technologies was founded in 2006.

  • Where is evoxx technologies's headquarters?

    evoxx technologies's headquarters is located at Alfred-Nobel-Str. 10, Monheim am Rhein.

  • What is evoxx technologies's latest funding round?

    evoxx technologies's latest funding round is Acquired.

  • How much did evoxx technologies raise?

    evoxx technologies raised a total of $7.22M.

  • Who are the investors of evoxx technologies?

    Investors of evoxx technologies include Advanced Enzyme Technologies, High-Tech Grunderfonds, Sirius Venture Partners, Roland Oetker, NRW.Bank and 4 more.

  • Who are evoxx technologies's competitors?

    Competitors of evoxx technologies include AOV.

You May Also Like

A
AOV

AOV produces and retails natural food supplements and nutritional supplements. It is based in Almere, Netherlands.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.